awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q55507456-2A7E41D8-6638-4CA5-A24D-62FC31441A4C
Q55507456-2A7E41D8-6638-4CA5-A24D-62FC31441A4C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55507456-2A7E41D8-6638-4CA5-A24D-62FC31441A4C
Real world study of regimen containing bevacizumab as first-line therapy in Chinese patients with advanced non-small cell lung cancer.
P2860
Q55507456-2A7E41D8-6638-4CA5-A24D-62FC31441A4C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55507456-2A7E41D8-6638-4CA5-A24D-62FC31441A4C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
789949ff31fcd1de29d55ca224a0dbd04453322f
P2860
Safety and efficacy of first-line bevacizumab with chemotherapy in Asian patients with advanced nonsquamous NSCLC: results from the phase IV MO19390 (SAiL) study.